rs41283630

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_173551.5(ANKS6):​c.664C>T​(p.Arg222Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00686 in 1,606,732 control chromosomes in the GnomAD database, including 68 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R222Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0052 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0070 ( 62 hom. )

Consequence

ANKS6
NM_173551.5 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.54

Publications

11 publications found
Variant links:
Genes affected
ANKS6 (HGNC:26724): (ankyrin repeat and sterile alpha motif domain containing 6) This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
ANKS6 Gene-Disease associations (from GenCC):
  • nephronophthisis 16
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nephronophthisis 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005607575).
BP6
Variant 9-98790302-G-A is Benign according to our data. Variant chr9-98790302-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00523 (797/152306) while in subpopulation SAS AF = 0.0236 (114/4822). AF 95% confidence interval is 0.0201. There are 6 homozygotes in GnomAd4. There are 377 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKS6NM_173551.5 linkc.664C>T p.Arg222Trp missense_variant Exon 2 of 15 ENST00000353234.5 NP_775822.3 Q68DC2-1B3KXP1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKS6ENST00000353234.5 linkc.664C>T p.Arg222Trp missense_variant Exon 2 of 15 1 NM_173551.5 ENSP00000297837.6 Q68DC2-1

Frequencies

GnomAD3 genomes
AF:
0.00523
AC:
796
AN:
152188
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00458
Gnomad ASJ
AF:
0.0132
Gnomad EAS
AF:
0.0173
Gnomad SAS
AF:
0.0234
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00585
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00806
AC:
1967
AN:
244172
AF XY:
0.00895
show subpopulations
Gnomad AFR exome
AF:
0.000855
Gnomad AMR exome
AF:
0.00517
Gnomad ASJ exome
AF:
0.0130
Gnomad EAS exome
AF:
0.0176
Gnomad FIN exome
AF:
0.000500
Gnomad NFE exome
AF:
0.00579
Gnomad OTH exome
AF:
0.00952
GnomAD4 exome
AF:
0.00703
AC:
10227
AN:
1454426
Hom.:
62
Cov.:
31
AF XY:
0.00741
AC XY:
5353
AN XY:
722448
show subpopulations
African (AFR)
AF:
0.00132
AC:
44
AN:
33378
American (AMR)
AF:
0.00471
AC:
210
AN:
44608
Ashkenazi Jewish (ASJ)
AF:
0.0150
AC:
390
AN:
26062
East Asian (EAS)
AF:
0.00985
AC:
389
AN:
39488
South Asian (SAS)
AF:
0.0211
AC:
1821
AN:
86126
European-Finnish (FIN)
AF:
0.000448
AC:
23
AN:
51324
Middle Eastern (MID)
AF:
0.0148
AC:
85
AN:
5752
European-Non Finnish (NFE)
AF:
0.00610
AC:
6756
AN:
1107652
Other (OTH)
AF:
0.00848
AC:
509
AN:
60036
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
720
1441
2161
2882
3602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00523
AC:
797
AN:
152306
Hom.:
6
Cov.:
32
AF XY:
0.00506
AC XY:
377
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00147
AC:
61
AN:
41576
American (AMR)
AF:
0.00458
AC:
70
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0132
AC:
46
AN:
3472
East Asian (EAS)
AF:
0.0174
AC:
90
AN:
5176
South Asian (SAS)
AF:
0.0236
AC:
114
AN:
4822
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00585
AC:
398
AN:
68018
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
40
80
119
159
199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00634
Hom.:
13
Bravo
AF:
0.00486
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00727
AC:
28
ESP6500AA
AF:
0.00148
AC:
6
ESP6500EA
AF:
0.00744
AC:
62
ExAC
AF:
0.00764
AC:
922
Asia WGS
AF:
0.0210
AC:
74
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis 16 Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.20
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.78
T
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
1.5
L
PhyloP100
2.5
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-3.1
D
REVEL
Benign
0.12
Sift
Benign
0.034
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.081
B
Vest4
0.24
MVP
0.64
MPC
0.11
ClinPred
0.022
T
GERP RS
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.063
gMVP
0.60
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41283630; hg19: chr9-101552584; COSMIC: COSV100782433; API